Bone-Related Issues in Oncology

S. Mujtaba Rizvi, Helen Collins, Alan Lipton

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter talks about five case studies in bone-related issues in oncology. Increased rates of bone loss are seen in certain cancer treatment settings. Chemotherapy-related ovarian failure, use of aromatase inhibitors (AIs), androgen deprivation therapy (ADT), and steroid use are common risk factors for cancer treatment- induced bone loss. The first case study talks about patients with metastatic disease. Breast, prostate, and lung cancers most commonly metastasize to the bone. The second case study talks about patients undergoing treatment with AIs, ADT, corticosteroids, and chemotherapeutics that lead to gonadal failure with an increased risk of developing osteoporosis. The chapter also presents questions and answers about the bone-related Issues in Oncology.

Original languageEnglish (US)
Title of host publicationCancer Consult
Subtitle of host publicationExpertise for Clinical Practice
PublisherWiley Blackwell
Pages867-871
Number of pages5
ISBN (Electronic)9781118589199
ISBN (Print)9781118589212
DOIs
StatePublished - Jun 20 2014

    Fingerprint

Keywords

  • Androgen deprivation therapy (ADT)
  • Aromatase inhibitors (AIs)
  • Bone loss
  • Oncology
  • Osteoporosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mujtaba Rizvi, S., Collins, H., & Lipton, A. (2014). Bone-Related Issues in Oncology. In Cancer Consult: Expertise for Clinical Practice (pp. 867-871). Wiley Blackwell. https://doi.org/10.1002/9781118589199.ch136